TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Helius Medical Technologies, Inc. Comments On Unusual Market Activity

  • By GlobeNewswire
  • Jan 5, 2021 4:05 PM EST
PRESS RELEASES

Helius Medical Technologies, Inc. To Present At Four Upcoming Investor Conferences In January

  • By GlobeNewswire
  • Jan 4, 2021 7:05 AM EST
PRESS RELEASES

Helius Medical Technologies, Inc. Announces Reverse Stock Split

  • By GlobeNewswire
  • Dec 31, 2020 7:05 AM EST
PRESS RELEASES

Helius Medical Technologies, Inc. To Present At Upcoming Investor Conferences In November

  • By GlobeNewswire
  • Nov 5, 2020 7:05 AM EST
PRESS RELEASES

Helius Medical Technologies, Inc. Announces The Expansion To A Total Of 27 Authorized PoNS Treatment™ Clinic Locations Across Canada

  • By GlobeNewswire
  • Nov 4, 2020 7:05 AM EST
PRESS RELEASES

Helius Medical Technologies To Release Third Quarter Of Fiscal Year 2020 Financial Results On November 12, 2020

  • By GlobeNewswire
  • Nov 2, 2020 5:00 PM EST
PRESS RELEASES

Helius Medical Technologies Announces Closing Of $3.4 Million Private Placement

  • By GlobeNewswire
  • Oct 26, 2020 5:44 PM EDT
PRESS RELEASES

Helius Medical Technologies Announces $3.4 Million Private Placement

  • By GlobeNewswire
  • Oct 21, 2020 4:32 PM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Provides Update On FDA's Review Of Its Request For De Novo Classification And Clearance Of The PoNS™ Device For The Treatment Of Gait Deficit Due To Symptoms Of Multiple Sclerosis

  • By GlobeNewswire
  • Oct 19, 2020 4:31 PM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Announces Partnership With Breakthrough Health For Multiple Sclerosis Insights

  • By GlobeNewswire
  • Oct 14, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Announces Formation Of Multiple Sclerosis Scientific Advisory Board

  • By GlobeNewswire
  • Oct 8, 2020 7:29 AM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. To Present At Three Upcoming Investor Conferences In September

  • By GlobeNewswire
  • Aug 31, 2020 2:00 PM EDT
PRESS RELEASES

Helius Medical Technologies To Release Second Quarter Of Fiscal Year 2020 Financial Results On August 12, 2020

  • By GlobeNewswire
  • Aug 10, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Submits Request For FDA Clearance For PoNS™ Device; Reports Preliminary Financial Results For The Second Quarter And Six Months Ended June 30, 2020

  • By GlobeNewswire
  • Aug 6, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies Announces The Dismissal Of The Shareholder Class Action Lawsuit

  • By GlobeNewswire
  • Jul 14, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies To Present At The Virtual Summer Summit On June 9th

  • By GlobeNewswire
  • Jun 5, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Announces FDA Has Granted The PoNS Device Breakthrough Device Designation For The Treatment Of Gait Deficits Due To Symptoms Of Multiple Sclerosis

  • By GlobeNewswire
  • May 12, 2020 7:05 AM EDT
PRESS RELEASES

UPDATE -- Helius Medical Technologies, Inc. Announces Publication Of Its PoNS™ Registrational Clinical Trial (TBI-001) In TBI

  • By GlobeNewswire
  • Apr 30, 2020 12:02 PM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Announces Publication Of Its PoNS™ Registrational Clinical Trial (TBI-001) In TBI

  • By GlobeNewswire
  • Apr 30, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies To Release First Quarter Of Fiscal Year 2020 Financial Results On May 7, 2020

  • By GlobeNewswire
  • Apr 22, 2020 4:05 PM EDT
PRESS RELEASES

Helius Medical Technologies Appoints Jeffrey S. Mathiesen To Its Board Of Directors

  • By GlobeNewswire
  • Apr 22, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies Announces Authorization From Health Canada To Market The PoNS™ Device For The Treatment Of Gait Deficit Due To Mild And Moderate Multiple Sclerosis (MS)

  • By GlobeNewswire
  • Mar 24, 2020 7:05 AM EDT
PRESS RELEASES

Helius Medical Technologies Announces $2.2 Million Registered Direct Offering

  • By GlobeNewswire
  • Mar 18, 2020 8:00 AM EDT
PRESS RELEASES

Helius Medical Technologies, Inc. Provides Details On Five Recently Authorized PoNS Treatment™ Clinics

  • By GlobeNewswire
  • Mar 9, 2020 7:05 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.